
Company valuation, historical trends, and peer comparisons.
According to Renalytix Plc’s latest financial reports and current stock price. The company's current Enterprise Value is 48.70M. This represents a change of 78.15% compared to the average of 27.34M of the last 4 quarters.
The mean historical Enterprise Value of Renalytix Plc over the last ten years is 200.37M. The current 48.70M Enterprise Value has changed -75.69% with respect to the historical average. Over the past ten years (40 quarters), RTNXF's Enterprise Value was at its highest in in the June 2021 quarter at 979.11M. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.
Average
200.37M
Median
66.25M
Minimum
14.38M
Maximum
993.54M
Discovering the peaks and valleys of Renalytix Plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 170.08%
Maximum Annual Enterprise Value = 993.54M
Minimum Annual Increase = -94.17%
Minimum Annual Enterprise Value = 14.38M
| Year | Enterprise Value | Change |
|---|---|---|
| 2026 | 16.81M | 16.88% |
| 2025 | 14.38M | -23.93% |
| 2024 | 18.91M | -81.97% |
| 2023 | 104.86M | 81.05% |
| 2022 | 57.92M | -94.17% |
| 2021 | 993.54M | 170.08% |
| 2020 | 367.86M | 125.91% |
| 2019 | 162.83M | 145.78% |
The current Enterprise Value of Renalytix Plc (RTNXF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
16.70M
5-year avg
42.58M
10-year avg
200.37M
Renalytix Plc’s Enterprise Value is greater than HS GovTech Solutions Inc. (21.92M), greater than Yourgene Health Plc (27.05M), greater than PharmChem, Inc. (20.37M), less than OKYO Pharma Limited (59.41M), less than Think Research Corporation (67.91M), greater than U.S. NeuroSurgical Holdings, Inc. (20.88M), greater than TPCO Holding Corp. (-8710833.00), less than Kubota Pharmaceutical Holdings Co., Ltd. (7.52B), less than Kadimastem Ltd (151.53M), greater than Biofrontera AG (15.69M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 21.92M | $21.13M | |
| 27.05M | $20.67M | |
| 20.37M | $21.95M | |
| 59.41M | $22.73M | |
| 67.91M | $17.81M | |
| 20.88M | $22.16M | |
| -8710833.00 | $20.12M | |
| 7.52B | $24.10M | |
| 151.53M | $9.50M | |
| 15.69M | $19.35M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Renalytix Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Renalytix Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Renalytix Plc's Enterprise Value?
What is the highest Enterprise Value for Renalytix Plc (RTNXF)?
What is the 3-year average Enterprise Value for Renalytix Plc (RTNXF)?
What is the 5-year average Enterprise Value for Renalytix Plc (RTNXF)?
How does the current Enterprise Value for Renalytix Plc (RTNXF) compare to its historical average?